Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
https://www.israelnationalnews.com/news/356245/?utm_source=webshare&utm_medium=social&utm_campaign=share&utm_content=1658246083278
“31% boosted people still contagious 10 days post-infection vs. 6% unvaccinated.
A new study published in the New England Journal of Medicine (NEJM)* has demonstrated that people who are triple-vaccinated (boosted) against COVID recover significantly more slowly from COVID infection and remain contagious for longer than people who are not vaccinated”
Seems shots aren’t keeping folks Covid free like originally hoped they might … the good thing is the escozine taken along with vaccines or if not vaccinated the escozine is a good therapeutic against Covid
https://patriotinsider.org/pfizer-trial-data-revealed-hospitalization-more-likely-with/
Stay healthy everyone
https://medoliferx.com/shop/drops/escozine-immunapen-original-drops/
I hope your stance is incorrect
Hopefully they are able to finalize with private investors as spoke of in the cc
Things in the works at the time of the CC :
41:25 Dilution discussed ** last stage of closing with investors attorney to “avoid future dilution”
42:00 investor engaging with FDA LOBBYIST to help FDA process
** investor has experience w distribution of Covid 19 vaccines
42:43 FDA status - discussed “second potential investor” - help to move application from pre Ind to Ind status
50:00-51:54 *LICENSING discussed*
Cc link and code link below;
Topic: Medolife Rx (Quanta, Inc. OTC: QNTA) Investor Conference Call
Date: May 12, 2022 04:52 PM Eastern Time (US and Canada)
Meeting Recording:
https://us06web.zoom.us/rec/share/bLPZGqeBj6t9ecgZBactMfKt6KOPXZ1Q5qYKn0z5KhawBW_vmc7JFeJNtPhjq0wk.gl8CdDheQtl33mSC
Access Passcode: $uPi^+4r
anger COULD be directed at the FDA … as it was the FDA that moved the goal post
Dr Mikaelian has spent close to 2 decades of research and refining, developing and testing the escozine …. Bringing it to the point where many on this board only but ever first heard of them last spring when shares were 0.05 Cents … it was a low share count and with positive feedback from the fda and excitement from investors the stock jumped to 0.20 Cents
It looked at that point a stock one could “almost” guarantee doubling money on or more in a short amount of time …
However … the fda directly because of the Covid vaccine concern now on how things affect humans at the dna level … instead of pushing escozine fwd (which is how it was looking it would go ..) the fda NOW has added testing … that NO ONE could foresee (not diff management not anyone on this board … no one, as it was new and the fda states as much )
Sooooo then with bad advice a rs was written in as something that could be used if needed to help leg up to Nasdaq. (This imo was where the spiral down in the sp truly began).
Ultimately lots of very unfortunate unforeseen things ….
Do I like the current sp ? No.
However, simply “selling the company” isn’t necessarily the right solution… why?
Because literally to get a drug to the stage Medoliferx got escozine takes many years and lots of funding …
The hopeful candidate for new shared ceo is one who has experience with the fda …
MedolifeRx is a small company
They have patents and products and have an exclusive agreement with the DR
Have a good weekend
GLTA
they have stated goals publicly
listen to latest the cc
At this Time stamp
13:40 QNTA Main GOALS & PLANS discussed
They’ve spelled out numerous things that were in the works Also I’ve shared the link before with detailed notes of where things were mentioned
I’ll paste my notes once again at the bottom of this note … with the link to watch the cc and the passcode at the very bottom of this page below the list of times of things discussed (for example at 13:40 minute mark QNTA Main GOALS & PLANS)
Should you want to reach out with specific questions/ concerns / ideas etc
Here is the contact information
ir@medoliferx.com
Below is a quick reference guide I compiled to easily pin points where topics were discussed on the CC many said they didn’t have time to watch in entirety so I took a morning and made notes … (it’s quite possible I missed something but it’s pretty comprehensive)
hopefully you find it helpful
HOWEVER if you have specific questions pertaining to the cc and or otherwise send an email mark it attention Grant Mikaelian and ask directly… the cc covers a lot and will give you a good starting point to hear the plans etc
key topics that were discussed
4:45 start time
6:20 begin investors Q&A
7:00 SEC discussed
7:31 Auditor change / 8k item 4.01 discussed
813 OTC OTCQB discussed
8:56 Farmatsevtik Armenia
13:40 QNTA Main GOALS & PLANS
17:35 some Paxlovid users had symptoms relapse, versus with escozine symptoms did not return
18:35 PROVISIONAL PATENT now “ABLE TO SHARE PUBLICLY” escozine Covid 19 therapy “important goal”
20:22 CHART escozine therapy results EFFICACY charts
21:36 patient LUNG X-ray showing ASTOUNDING RESULTS from MONOTHERAPY escozine
22:54 Chief Scientific Officer Dr Matalka breaks down escozine ** lots of very good informative easy to follow slides - science of escozine explained very well *** worth listening / watching this portion, great visuals and easy to understand science of how Escozine works against Covid
26:36 *** [ “polarization of escozine significantly increased cox-2 inhibition in comparison with non polarized venom”]***<<
31:38 slide shown Escozine BLOCKS omicron
32:50 “beauty of Escozine”
33:30 explains COVID registration PROCESS versus CANCER Registration process
35:05 delay in Dominican Republic studies explained (** worth noting, ANY medical trial is at the mercy of available subjects that fit in a specified sub group etc .. Covid rates WERE down … NOW going back UP )
36:37 currently Mexico has ENOUGH patients for DOUBLE BLIND study
37:13 Mexico EXPORT certificate (explains easier to import from US to Mexico .. double blind test mentioned again)
38:06 *** FDA strategy summarized
“Actively working to completely FDA process”
*** Funding discussed to finished indoor facility in DR
41:25 Dilution discussed ** last stage of closing with investors attorney to “avoid future dilution” ***
42:00 investor engaging with FDA LOBBYIST to help FDA process
** investor has experience w distribution of Covid 19 vaccines
42:43 FDA status - discussed “second potential investor” - help to move application from pre Ind to Ind status
43:08 a vision for DISTRIBUTION and New Opportunities
46:25 WALGREENS dialogue .. speaker has “experience in retail space for 30 years” … meeting with WALGREENS mentioned
49:28 Kevin Harrington (spelling??) Group REACHED out To QNTA expressing interest in Representing them - product samples to be shipped
50:00-51:54 *LICENSING discussed*
(noted / reminder in the CC big pharma moves slow / process takes time)
51:56 name & SYMBOL CHANGE addressed
52:45 VENDING MACHINE lease discussed - modern style with visual screens for product video (ability to have video screen on the machine itself is what I understood)
53:57 “Shared CEO” position defined - active negotiations for CEO position, third round of interviews completed - CANDIDATE has extensive biotech experience & EXPERIENCE in taking Otc company(s) to NASDAQ
- roles of co-ceo positions discussed
55:50 addressed the PRE IND # and shows slide with direct communication with FDA showing the validity of the pre Ind #
56:45 dispels myth of his salary
57:25 “life’s work” *** worth hearing this portion, imo, shows a testimony and drive of the culmination of research to where qnta is now and moving forward toward to a continued path to achieving goals
***
GLTA
***
Cc link and code link below;
Topic: Medolife Rx (Quanta, Inc. OTC: QNTA) Investor Conference Call
Date: May 12, 2022 04:52 PM Eastern Time (US and Canada)
Meeting Recording:
https://us06web.zoom.us/rec/share/bLPZGqeBj6t9ecgZBactMfKt6KOPXZ1Q5qYKn0z5KhawBW_vmc7JFeJNtPhjq0wk.gl8CdDheQtl33mSC
Access Passcode: $uPi^+4r
Telling what? Let me be EXTREMELY CLEAR I am NOT happy with the current share price. I am down just like everyone else who invested a year ago right before the price jumped to $0.20 cents …
It’s literally a huge heart ache to see the giant bold in red percentage down in my trading account … believe me, I’m Not “happy” with how the series of events got us here to this extreme price …
However, when i initially invested, I did not invest as flip … I seriously dug into the science and have real hope the venom will become more useful in many applications
The fda was giving MedilifeRx great feedback and forward direction … THEN because of the Covid vaccines … right when escozine prior Would have been pushed forward …. Because of the civid vaccine Now drugs are required to go through an additional very expensive testing on how it will affect the dna (this test obviously was anticipated as it had never been required before)
Add in the awaited for imunapen packaging delay in shipping (this was also unfortunate as I also know store owners who had to now wait many months for what used to be weeks for some thing)
The RS debacle … another unfortunate situation… I honestly believe had they not been given the advice to have that put in the wording the stock sp would be different right now … but I digress …
Because of Covid they had the big opportunity meet and greets canceled
The nfl one in las Angeles and the various dicks sporting goods ones (now Near me dicks is closed completely … many businesses went out during and because they didn’t survive Covid and the economy)
I could stomp around and chime in yelling and screaming and saying I’m angry about the share price … but I didn’t. Plenty of angry posts already … which the valid concerns I took and then went straight to qnta to start asking … I’m down currently and don’t like it … but instead of screaming I sought out answers ..
I think a big thing many are upset about is this stock looked like a sure “quick” win with how the numbers looked last year ..
Many if not most companies fail, many never stay open past the first few months of business.. qnta is definitely down but not out …. I’m NOT trying to suggest to any one ever that they buy or sell shares …
However, legitimately I do like and use their products… so, why do I continue to suggest the products??!
a) they work
b) more people try the more the products have chance for customers to re purchase and or gift to others (you know the old hair care ad? “And they told two friends and they told two friends and so on and so on”)
C) maybe just maybe product gets shared with some one who could assist in propelling the company fwd
I’m tired of being harangued … I’m simply an investor who when folks posts things that seriously make eye brows raise (mine included) instead of just being angry I communicate with the folks at qnta …
Literally I’ve only ever sought to add to the board is information … just because I do that doesn’t tell anything … other than I’m trying to share information that clearly not many have the time to get. Many said they didn’t have time to watch the cc so I made notes to be helpful….
Ultimately I’m invested, and in life on any level of day to day I’ve never liked when statements are blatantly false .. so I’ve sought out answers and subsequently posted them
GLTA
And once again Covid is on an ugly rise and new variants … never mind the stock
The immunipen helps - while because of fda they can’t advertise imunapen for Covid … we have all seen the data for escozine and Covid as a therapeutic
So with that I wish good health to everyone as we are living in weird times
https://medoliferx.com/shop/drops/escozine-immunapen-original-drops/
Nope… I’m not paid … just an investor..
Noteworthy I’m not one to suggest any one buy or sell anything.. however I’ll seek out answers when questions come up though … I do use and like their products, I find that they work great as advertised …
It’s Nice of you to stop by and say
Hiiiiiiii 8~)
Hope your doing well :)
& Hi!!!! Back at you
Yawn …
They are working on securing the co-CEO as discussed in the cc
As noted in the Cc the candidate has great experience with the fda among other things …
On the Covid front more crazy variants emerging Stay healthy everyone
Hardly … “The son hides in the Dominican and does nothing all day running up huge expenses.” He’s not hiding … and you can easily contact him …
I’m not defending the share price .. however there is consistent hyperbole that says they can’t be contacted … I’ve had both phone calls and conference calls and email contact with a few folks from qnta
My thought, what I suggest in earnest, is for folks with questions / concerns, to take the time to reach out for themselves to the company. I’ve contacted qnta with questions and subsequently secured answers that I myself found satisfactory, however it is up to each individual to do their own DD and come to conclusion on their own. I’m personally invested, I’m also unhappy with how how this last year played out, however it’s been an incredibly unfortunate series of events that got us here. That all being said, it’s worth noting they (qnta) have not given up… and continue to work towards moving things forward
“ :) “
This is a matter to smile at ???
Odd
“How do you feel about the management of this company? Should they remain in charge? “. My answer,is yes, I think they should remain in charge ALONG side / in conjunction with the new shared ceo they are finalizing ties with.
https://redaccionrd.com/8749-medicos-afirman-escozine-da-resultados-positivos-en-pacientes-de-covid-19-y-cancer
This may not be “new” news …
but it’s still good news ;)
Insert eye roll, seriously this is your proof .. [{“no "email header"}] .. I copy and pasted the words from the email exactly.. this being a casual forum I saw no need for more than AS ANYONE can easily reach out to the company and get an email DIRECTLY FROM the source themselves COMPLETE_with_header …
It’s one thing to share facts and ideas it’s another to accuse others of posting fake things when clearly I’ve shared all the contact information for ANY and EVERYone who wants to verify information can Themselves by simply reaching out to the company… some one asked a question I obtained an answer … in other words adding to the conversation…
Here’s the link & email address again for any and all investors who have questions and want to hear from the company directly as opposed to reading others assumptions I encourage speaking to the source
ir@medoliferx.com
https://ir.quantrx.com/
https://medoliferx.com/shop/drops/escozine-immunapen-original-drops/
The argument was stating the email wasn’t real. I’m tired of silly accusations … opinions are one thing, but the email is real. Some one asked a question, I got an answer…. Simply by asking
“The supposed email from the KID”
It’s real … doesn’t take much to quantify it either .. A question was asked I obtained an answer FROM the source . Everyone is welcome to email the company themselves. You’ll find the people exist, the products exist.
Here’s the link for
Grant Mikaelian at
ir@medoliferx.com
https://ir.quantrx.com/
There was photos and an explanation as well. The question was a asked so I referred to where it was discussed… ultimately we know the scorpions are there never mind the indoor project status the outdoor facility is operating and subsequently supplying the venom for the escozine production…
In the mean time, which I think is prudent on their part they discussed the status on the cc.
Folks can contact them directly with specific questions…. Which is what I do when I have a question… here’s the email address for question
ir@medoliferx.com
https://ir.quantrx.com/
This was explained and discussed in the last CC …
Here is the link
Meeting Recording:
https://us06web.zoom.us/rec/share/bLPZGqeBj6t9ecgZBactMfKt6KOPXZ1Q5qYKn0z5KhawBW_vmc7JFeJNtPhjq0wk.gl8CdDheQtl33mSC
Access Passcode: $uPi^+4r
Hi! I emailed your question directly to Grant Mikaelian himself, (fyi in case folks do not have here is the qnta ir email contact ir@medoliferx.com )
I emailed as i felt you had a good question… and Grant himself concurred and wrote back the following response via email which I just received - here it is verbatim copied and pasted below;
[{“That is an excellent question and I would be wondering the same thing if I was in the position of our investors. It is difficult for me to quantify my responsibilities, as my involvement in the day-to-day operations of the company is not limited to specific departments or projects. Some areas that I have less involvement would have to do with the science and technology aspects of the business, which my father and professionals in their respective industries work on, and whom I still assist as needed. While I do reside in the Dominican Republic for the time being to serve as the local company representative during the times my father is working in the United States, most of my work is done remotely on a computer and my physical location does not affect my ability to perform the plethora of tasks involving communications, documentations, negotiations, commerce, marketing, investor relations, regulatory, legal and many other areas that encompass the company's operations. My primary focus has always been in assisting the company and, in turn, my father in realizing the major goals set out, such as registering Escozine as a therapeutic for COVID-19 and cancer in the United States, and making Medolife's life-saving products available to more people.
I do not tend to toot my own horn, and I am not one to seek attention and recognition. However, I have been working with Medolife since early 2013 and I am dedicated, determined and loyal to the mission. There is nothing I want more out of my employment than to realize the company's goals, and to bring joy to all who have supported us along the way when they know they have made a significant and positive change in the world.
I hope I was able to answer your questions.
Sincerely,
Grant Mikaelian
Executive Vice President “}]
https://jennifermargulis.substack.com/p/40000-deaths-but-no-recall?fbclid=IwAR3EEJeoWCcP6f7b5FNRdggnlRCTtySG3bbtAWlzFyxNWGeXnSNYDRBfzys
This article is yet Another plethora of reasons Why I personally use the immunipen DAILY … escozine, for myself, as I have had NO side affects, immunipen works as advertised - and I’ve personally avoided contracting Covid thus far & / or symptoms were reduced so much so I never knew I had it … the below article is great - what we know, escozine works, what we also know - MANY other Covid treatments seemingly do not …
The current share price is abysmal, I cannot deny that, however, on a health note the below article reminds us why we need more products / alternatives on the market to help combat Covid like escozine
https://jennifermargulis.substack.com/p/40000-deaths-but-no-recall?fbclid=IwAR3EEJeoWCcP6f7b5FNRdggnlRCTtySG3bbtAWlzFyxNWGeXnSNYDRBfzys
https://medoliferx.com/shop/drops/escozine-immunapen-original-drops/
[{“On June 29, 2022, Dr. Peter McCullough, M.D., testified to the Texas Senate Health and Human Services Committee about what we have learned during the COVID-19 pandemic. He called his 17-minute presentation “Pandemic Lessons Learned.”
Who is Peter McCullough, M.D.?
Peter McCullough is one of the country’s best published and most respected cardiologists. He has practiced conventional cardiology throughout his successful career and never had a reason to question medical authority or vaccine safety. All of that changed during COVID. As he explained to the same committee in March of 2021 (you can find a transcript of that testimony on my website), McCullough was deeply disturbed that the medical establishment insisted COVID wasn’t treatable.
You can read the full transcript of his testimony below. But for anyone who wants the cheat sheet…
The Most Important Take-aways:
1. COVID-19 is treatable. Early treatment reduces your risk of hospitalization and death by 95 percent, according to Dr. McCullough.
2. Remdesivir is not a safe or effective drug and should not be used to treat COVID-19
3. Vaccines against COVID-19 were not adequately studied before being made available to the public.
4. COVID-19 vaccine program should be immediately halted worldwide.
5. Doctors, nurses, and patients who share their stories should not be censored or vilified. We need to pay attention to their experiences, not seek to silence them.
Pandemic Lessons Learned
Dr. Peter McCullough: Madam chairman, ladies and gentlemen: I am probably well known to the committee, I testified here on March 10th, 2021. I’m a practicing internist and cardiologist in Dallas, Texas, and I'm an expert on COVID-19.
I have 56 peer-reviewed publications on the pandemic. Particularly, on how to treat the infection, and over 770 overall publications in the National Library of Medicine, and well over a thousand overall medical communications.
I’ve served on two dozen data-safety monitoring boards for large pharmaceutical and device and in vitro diagnostic studies; and I consider myself both an expert on the COVID-19 virus as well as on drug and device and biological agents safety.
Here are my comments.
A Duty to Treat the Patient
There has always been a duty to treat COVID-19. It started with the very first case—as soon as we recognized that this was a potentially fatal infection.
When a patient could have died of this infection, at that moment, and we understood it early based on risk stratification (based on age, medical problems, and severity of symptoms upon presentation), there was a duty to treat that patient. Period.
If a doctor did not treat that patient when a patient sought help, there was a duty to refer. From the very beginning, there was a community standard of care—though from the very beginning, it evolves over time. In many situations like this or with rare diseases, the community standard of care may be one doctor in that community who's going to take on the challenge of treating that patient—but that becomes the community standard of care.
Early, there was use of a variety of drugs that became standard of care, as evidenced by surges in use of these drugs, and they included hydroxychloroquine, ivermectin, prednisone, and budesonide. There were giant surges and use of these drugs as evidence that these were outpatient evolving standards of care.
Now there is surge of use in Paxlovid and a minor surge in Molnupiravir.
There has always been a community standard of care for early treatment.
Lessons learned for this committee. There have been eight hours of testimony today. [But] not a single presenter could tell you what patients in these data sets received early treatment and what was their outcomes. Not a single presenter knew who had received early treatment and what was the degree of complexity of that early treatment.
Next Time We Must Convene an Early Treatment Committee
Lesson learned. Next pandemic immediately get an outpatient early treatment committee together. Their objective is to reduce the risk of hospitalization and death. That is the overall objective of this pandemic: Keep people out of the hospital and keep them alive. If they can get through this illness at home, that was your mission from the very beginning on early treatment.
Fortunately, there have now been about 1,400 studies. There have been hundreds and hundreds of randomized trials. And we know that sequenced multi-drug therapy that addresses viral replication, inflammation, or cytokine storm and thrombosis is the approach in handling this.
Dr. Procter is here. He's published two very good studies right from the state of Texas. Dr. Vladimir Zelenko in Monroe, New York. Dr. Raoult in France.
All the data are cohesive: that the early protocols—the very early—had 85 percent reductions in the risk of hospitalization and death.
Early Treatment Reduces Risk of Death by 95 Percent
Now with monoclonal antibodies, Paxlovid, and others, I've testified under oath in the U.S. Senate on January 24th, 2022, based on my expert opinion there is now a 95 percent risk reduction for death and hospitalization if early treatment is provided.
Conversely, I've reviewed hundreds if not thousands of reports of patients who were hospitalized and died. Hundreds, if not thousands of reports. The real outcome of hospitalization and death is a product of not receiving early treatment.
Whether someone's vaccinated or not, the vaccination is irrelevant because the vaccination is not a treatment.
What's relevant is: Was the patient treated before the hospital? And every single case, and in every single patient outcome that I can see, the reason why they were in the hospital is they received either zero outpatient treatment or they received inadequate treatment that was received too late.
So a committee like this lesson learned: it's always going to be about treating the next infectious disease early.
In terms of inpatient care and the overall landscape of what happened timeline, I think the charge of the committee is pay attention to big developments! Pay attention to these.
In May of 2020, there was a U.S. Senate hearing on the use of corticosteroids. Pay attention to that … You heard confusing testimony. Some of these doctors didn't know if steroids worked or not. That was a landmark event, where it was clear that steroids worked, and it should have rapidly been instituted as a standard of care in the hospital.
Another giant development was I had published the first overall treatment protocol paper in a major medical journal, August 7th of 2020, but rapidly after that in September of 2020 there already was a home treatment guide by the Association of American Physicians and Surgeons. When there is a physician group that publishes a home treatment guide, pay attention to that.
Remember the Infectious Disease Society of America always had the first set of guidelines and then the NIH. They still to this day do not have a comprehensive outpatient treatment guideline.
That's the reason why AAPS filled in, Frontline Critical Care Network filled in, Truth for Health Foundation, Frontline Doctors, and others. When other physician organizations based on consensus and data fill in the gaps, pay attention to that. Very very important.
Remdesivir Responsible for Kidney, Liver Injury
When an organization puts out a negative position on a drug. A negative position. This is really important and it's a worldwide organization, you must pay attention to this.
November of 2020, the World Health Organization says stop using remdesivir. Stop it! It's bad. It doesn't work and it’s leading to more deaths, it leads to kidney injury and liver injury.
The immediate thing this committee should have done is [address who's using remdesivir in the state of Texas and let's talk about it.
Now whether or not the NIH disagrees with it or the WHO, that’s got to be vetted, but the question should have been asked. We needed to reexamine this. Were Texans going to be hurt by this drug?
The World Health Organization, European Society of Critical Care said yes [people were hurt by remdesivir]. And that went on under this committee's watch.
These are very very important. Lesson learned. Pay attention to the big developments.
We've covered monoclonal antibodies well enough.”}]
Agree the Products are legit … sometimes even when things look abysmal it can turn around if / when the product is good / has value
Here’s an example / story of someone who by all means by onlookers accounts was clearly “failing” at every turn … preserved and persisted to try anyways …
A never give up story …
Fitting to share since we just celebrated the Fourth of July
Abraham Lincoln
"This man was born in 1809.
In 1816, at age 7, he was forced to work because his family was expelled.
In 1818, he lost his mother.
In 1828, he lost his sister.
In 1831, he opened his first business and went bankrupt.
In 1832, he stood in the legislative elections and lost.
In 1833, he borrowed money to open another business and went bankrupt again.
In 1835, he met a wonderful woman. He falls in love with her, they get engaged, and she dies.
In 1836, he entered a dark period of his life: deep depression.
He remains bedridden for 6 consecutive months. But he gets up.
He gets up and in that same year of 1836 he runs in the legislative elections and loses again.
In 1840 he presented himself as an elector; he loses.
In 1842, he met the woman he would end his life with.
They fall in love, get engaged, get married and she gives him 4 children and they lose 3 (three).
In 1843, he appeared at the congresses and lost.
In 1845, he appeared again at the congresses and lost again.
In 1850, his son died.
In 1854, he ran for the Senate and lost.
In 1856, he ran for Vice President, he didn't even have 100 votes.
In '58, he ran again for the Senate and lost again.
And in 1860 ABRAHAM LINCOLN was elected President of the United States of America
He was elected for two exceptional terms (he was assassinated in beginning of the second term.) He was one of the most respected and impactful Presidents in the history of the United States
It's important to tell this story of perseverance because we see the hero, but we don't see the backstage of the afflictions. "
Wow. ...
I think this is a great example of Never Never Never Give Up!
"If you asked me about reinfection maybe a year and a half ago, I would tell you that maybe I have a patient here or there, but it's really, really rare," Al-Aly said. That's not true anymore, though.
https://www.cnn.com/2022/07/05/health/covid-reinfection-risk/index.html
The science shows that escozine is effective against Covid … I’m not entirely sure of the dosage amount given to Covid clinical trial subjects … however I can say I’ve been using the escozine immunipen daily - and twice daily when I’ve been exposed to family / friends who had Covid and I’ve managed to avoid getting it myself thus far …. Is it the immunipen? Or am I lucky? Who knows … but I do know the immunipen works as described and I’m enjoying the benefits I can observe like improved sleep for example ..
https://medoliferx.com/shop/drops/escozine-immunapen-original-drops/
Good point
Why so many “ :) “ smile faces?
I don’t understand the joy ?
Wishing everyone a happy Fourth of July
“From past experience, if investors don’t panic sell, the share price will jump big time. Being a CE will force a lot of the mm’s / shorts to liquidate and close out. We could see the sell price jump to at least .03 if panic selling doesn’t take place”
… good information, thank you
[{“We contend that we have not committed any wrongdoing or the violations referred to in the Notice”}]
They do have real products, that do work … and since this is the United States an opportunity to defend themselves.
For those of us who have taken the time to try the products .. we that have actually used them know they do indeed work as advertised
Making this statement from the posting false
[{“Quote:
At least the muscle rubs work. Right?
I seriously doubt that's even true. “}]
What’s amazing is how anyone can say sometime doesn’t work YET clearly hasn’t even tried the products
Here’s a testimonial
Quote from Tony Hawk: “Because I’m still so active, I’m constantly looking for the most effective hemp oil extract products and post skate recovery. AELIA consistently works well for me, so it’s my first choice.”
… My parents are elderly and love the muscle rub as it works well … my Dad ordered the muscle rub, as he’s also an investor, he wanted to try the product before he invested - he found the products to work as advertised
https://aeliastore.com/
As I said … we don’t have all the information… they claim they can defend their stance and have explained and answered things on the Cc. Along with others I contend they deserve the opportunity to defend themselves. We do not know specifically anything … vague speculation and screaming Russia means zero … the Armenian company transaction was explained as was the import tax changes and the verbiage of “homeopathic” vice “supplement” etc for escozine and immunipen
What we Do know is the products DO WORK as described and are available.. we do know the fda has given promising feedback as they continue to move forward ….
Qnta will not be the first or the last company to be put under a microscope… they have a unique product and literally anything “Covid” related created a political scrutiny level unlike anything I’ve ever scene …. Unless your name is Pfizer that is …
Anyways …. Point being, they like everyone deserves opportunities to defend their stance …
Also, Covid on the rise again I know a vaccinated family with Covid for the third time. I myself have been using the escozine immunipen to help keep my immune system boosted …
If as an investor one hasn’t tried the products yet I highly recommend them - they are real products, are available, and work as described
GLTA
Here’s a product link
https://medoliferx.com/shop/drops/escozine-immunapen-original-drops/
Since we do not have all the information.. ie we do not know what the details of investigation or allegations are … it is quite possible that there isn’t much else for them to be able to state publicly other than : “We contend that we have not committed any wrongdoing or the violations referred to in the Notice.”
“Monotherapy”!!! Covid isn’t going away I know folks who’ve had it three times now .. and are vaccinated… mean while I’m using the imunapen escozine myself
“we saw that after four to five days of taking Escozine as a monotherapy, all COVID-19 positive clinical participants had a significant improvement and tested negative for the virus within a week time. The drug contains four small molecular peptides that block ion channels causing a multi-action effect on the SARS-CoV-2 pathogenesis as both a therapeutic and palliative potential drug.”
https://www.globenewswire.com/en/news-release/2021/06/23/2251802/0/en/FDA-Accepts-COVID-19-Clinical-Study-and-Advises-on-Next-Steps-for-Pre-IND-Filing-by-Medolife-Rx.html
[{“QNTA's Position:
We contend that we have not committed any wrongdoing or the violations referred to in the Notice. We cannot predict whether the Commission will follow the recommendations of the staff and file suit against us. If any enforcement proceeding is instituted by the Commission, we will defend the action.”}]
Momentum has a lot to do with perspective
In regards to the fda process they have forward momentum in regards to escozine.. they continue to do what is asked of them by the fda and have continued with double blind tests etc fulfilling queries asked of them by DR & fda in order to propel things forward according to guidance given to them …
This is is 17-20 years of research to this point … pharma things take time and often have a very slow process until they reach the goal of finalizing deals / garnering approval
Good morning :~) GLTA MedolifeRx QNTA E$COZINE AELIA https://www.pharmacompass.com/pipeline-prospector-drugs-in-development/medolife
Good morning all
Hopefully every one had a nice long Father’s Day weekend
Here’s to new news (by end of July would be awesome in the mean time I picked up some more shares this morning)
GLTA
Dividends … nice!